Evidence map›Paper›PMID 40947526›Full record

ReviewJournal of cataract and refractive surgery2026

Hyperopic keratorefractive lenticule extraction.

Dan Fu, Ruoyan Wei, Meipan Shi, Xiaoliao Peng, Xingtao Zhou, Tian Han

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Journal of cataract and refractive surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Dan FuFrom the Department of Ophthalmology, Eye and ENT Hospital of Fudan University, Shanghai, China (Fu, Wei, Shi, Peng, Zhou, Han); NHC Key Laboratory of Myopia (Fudan University), Shanghai, China (Fu, Wei, Shi, Peng, Zhou, Han); Research Center of Ophthalmology and Optometry Shanghai, Shanghai, China (Fu, Wei, Shi, Peng, Zhou, Han); Shanghai Engineering Research Center of Laser and Autostereoscopic 3D for Vision Care, Shanghai, China (Fu, Wei, Shi, Peng, Zhou, Han); Shanghai Medical College and Zhongshan Hospital Immunotherapy Translational Research Center, Shanghai, China (Wei).
Ruoyan Wei
Meipan Shi
Xiaoliao Peng
Xingtao ZhouORCID 0000-0002-3465-1579
Tian Han

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Keratorefractive lenticule extraction (KLEx) is a cutting-edge refractive surgery technique that has garnered considerable attention in recent years due to its minimally invasive nature and the absence of a corneal flap both of which are notable advantages over traditional laser-assisted in situ keratomileusis surgery. Currently, the technology for myopia correction using KLEx has been refined and is widely recognized. Consequently, hyperopic KLEx surgery is highly anticipated, having undergone nearly a decade of evolution and development, and it seems to have finally achieved stable and reliable postoperative outcomes. This article reviews the emerging hyperopic KLEx in clinical outcomes, challenges, complications, and outlook.

Indexed as

Corneal StromaCorneal Surgery, LaserHyperopiaHumansKeratomileusis, Laser In SituLasers, ExcimerMyopiaRefraction, OcularVisual Acuity

Identifiers

PMID40947526
PMCPMC12777594

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.